High power implantable battery with improved safety and method of manufacture

• US 7,209,784 B2
• Filed: 03/31/2003
• Issued: 04/24/2007
• Est. Priority Date: 03/31/2003
• Status: Active Grant

• Current Assignee: Medtronic Incorporated (Medtronic Plc)
• Original Assignee: Medtronic Incorporated (Medtronic Plc)
• Inventors: Schmidt, Craig L.
• Primary Examiner(s): MANUEL, GEORGE C
• Application Number:
  US10/403,114
• Publication Number:
  US 20040193227A1
• Time in Patent Office: 1,485 Days
• Field of Search: 607/5, 607/18, 429/9
• US Class Current: 607/5
• CPC Class Codes: A61N 1/378 Electrical supply
• CPC Class Codes: A61N 1/39622 Pacing therapy
• CPC Class Codes: A61N 1/3975 Power supply A61N1/378 takes precedence
• CPC Class Codes: H01M 4/381 Alkaline or alkaline earth metals elements H01M4/40 takes precedence
• CPC Class Codes: H01M 4/50 of manganese
• CPC Class Codes: H01M 6/16 with organic electrolyte H01M6/18 takes precedence
• CPC Class Codes: H01M 6/42 Grouping of primary cells into batteries H01M6/40 takes precedence
• CPC Class Codes: Y02E 60/10 Energy storage using batteries
• CPC Class Codes: Y02P 70/50 Manufacturing or production processes characterised by the final manufactured product

Abstract

Implantable medical devices in embodiments of the invention may include one or more of the following features: (a) a hermetic enclosure, (b) a low-power control circuit located in the enclosure, (c) a high-power output circuit located in the enclosure for delivering an electrical pulse therapy, (d) a power source and circuitry located in the enclosure for powering the low-power control circuit and the high-power output circuit, the power source and circuitry, (e) a first high-rate cell, (f) a second high-rate cell electrically connected in parallel to the low-power control circuit and the high-power output circuit, (g) and at least one resistive load electrically connected between the first high-rate cell and the second high-rate cell, the at least one resistive load having a resistive value to limit, in the event of an internal short in one of the high-rate cells, the rate by which the shorted high-rate cell drains the other high-rate cell.

Claims

1. An implantable medical device comprising:

a hermetic enclosure;

a low-power control circuit located in the enclosure;

a high-power output circuit located in the enclosure for delivering an electrical pulse therapy; and

a power source and circuitry located in the enclosure for powering the low-power control circuit and the high-power output circuit, the power source and circuitry, said power source and circuitry further comprising;

a first high-rate cell having a resistance R;

a second high-rate cell having a resistance R;

wherein the first high-rate cell and second high-rate cell are electrically connected in parallel to the low-power control circuit and the high-power output circuit; and

at least one resistive load having a resistance at least 10 times greater than the resistance R electrically connected between the first high-rate cell and the second high-rate cell, the at least one resistive load having a resistive value to limit, in the event the first high-rate cell being internally shorted, the rate at which such internally shorted first high-rate cell drains the second high-rate cell.

2. An implantable medical device of claim 1, wherein the at least one resistive load value being between 10 ohms and 100 ohms.

3. An implantable medical device of claim 1, wherein the first high-rate cell and the second high-rate cell include an electrode surface area up to 90 cm² each.

4. An implantable medical device of claim 3, wherein the electrode surface area being between 65 cm² and 90 cm².

5. An implantable medical device of claim 1, wherein the first high-rate cell and the second high-rate cell are maintained within a single case.

6. An implantable medical device of claim 1, wherein the first high-rate cell and the second high-rate cell includes a cathode, and further wherein the first high-rate cell and the second high-rate cell share a common anode.

7. An implantable medical device of claim 1, wherein the first high-rate cell and the second high-rate cell includes an anode, and further wherein the first high-rate cell and the second high-rate cell share a common cathode.

8. An implantable medical device of claim 7, wherein the cathode being selected from the group consisting of sliver oxide, vanadium oxide, silver vanadium oxide, manganese dioxide, copper oxide, copper silver vanadium oxide, lead oxide, carbon monoflouride, chromium oxide, bismuth-containing oxide, copper sulfate, and mixtures thereof.

9. An implantable medical device of claim 8, wherein the anode of the first high-rate cell and the anode of the second high-rate cell are formed from lithium.

10. An implantable medical device of claim 1, further comprising a switching circuit electrically connected between the first high-rate cell and the second high-rate cell for selectively coupling the first high-rate cell to the second high-rate cell upon activation of the high-power output circuit.

11. An implantable medical device having a hermetic enclosure for an, electrochemical battery, comprising:

a) a first high-rate electrochemical cell having a resistance R comprising;

i) a first anode;

ii) a first terminal for connecting the first anode to a first external lead;

iii) a first electrolyte operatively associated with the first anode; and

b) a second high-rate electrochemical cell having a resistance R comprising;

i) a second anode;

ii) a second terminal for connecting the second anode to a second external lead;

iii) a second electrolyte operatively associated with the second anode; and

c) a cathode electrically associated with the first electrolyte and the second electrolyte, wherein the first cell being connected in parallel to the second cell; and

d) at least one resistive load having a resistance at least 10 times greater than the resistance R electrically connected between the first external lead and the second external lead.

12. An electrochemical battery of claim 11 wherein the first and second high-rate cells discharge at a generally equal rate.

13. An electrochemical battery of claim 11 wherein the first high-rate cell and the second high-rate cell are housed in one casing.

14. An electrochemical battery of claim 11 wherein the first electrolyte and the second electrolyte are the same electrolyte.

15. An electrochemical battery of claim 11 wherein the at least one resistive load has a resistive value to reduce, in the event of an internal short in one of the high-rate cells, the rate at which the shorted high-rate cell drains the other high-rate cell.

16. An electrochemical battery of claim 15 wherein either high rate cell being able to provide power for a circuit in the event of a short in the other high rate cell.

17. An electrochemical battery of claim 15, wherein the at least one resistive load value being between 10 ohms and 100 ohms.

18. An electrochemical battery of claim 11, wherein the first high-rate cell and the second high-rate cell has a combined anode and cathode surface area of up to 180 cm².

19. An electrochemical battery of claim 18, wherein the combined anode and cathode surface area being between 130 cm² and 180 cm².

20. An electrochemical battery of claim 11, wherein the first terminal and the second terminal are the same.

21. A method for manufacturing an implantable medical device having a hermetic enclosure for an, electrochemical battery comprising the steps of:

a) providing a first high-rate electrochemical cell having a resistance R, comprising the steps of;

i) providing a first cathode;

ii) connecting a first external lead to the first cathode;

iii) activating the first high-rate cell with an electrolyte solution operatively associated with the first cathode; and

b) providing a second high-rate electrochemical cell having a resistance R, comprising the step of;

i) providing a second cathode;

ii) connecting a second external lead to the second cathode;

ii) activating the second electrochemical cell with the electrolyte solution operatively associated with the second cathode; and

c) associating an anode electrically with the electrolyte in the first high-rate cell and the second high-rate cell, wherein the first cell being connected in parallel to the second cell; and

d) connecting at least one resistive load having a resistance at least 10 times greater than the resistance R electrically between the first external lead and the second external lead.

22. A method of claim 21 wherein the first and the second high-rate cells discharge at a generally equal rate.

23. A method of claim 21 further comprising the steps of connecting electrically the anode to a battery casing to provide a negative charge on the casing.

24. A method of claim 21 wherein the cathode of the first high-rate cell and the cathode of the second high-rate cell are selected from the group consisting of sliver oxide, vanadium oxide, silver vanadium oxide, manganese dioxide, copper oxide, copper silver vanadium oxide, lead oxide, carbon monoflouride, chromium oxide, bismuth-containing oxide, copper sulfate, and mixtures thereof.

25. A method of claim 21, wherein the anode being formed from lithium.

26. A method for manufacturing an implantable medical device comprising the steps of:

a) providing a hermetic enclosure;

b) providing a low-power control circuit in the enclosure;

c) providing a high-power output circuit in the enclosure for delivering an electrical pulse therapy; and

d) providing a power source and circuitry in the enclosure for powering the low-power control circuit and the high-power output circuit, comprising the steps of;

i) providing a first high-rate cell having a resistance R;

ii) providing a second high-rate cell having a resistance R;

iii) connecting the first cell and second cell electrically in parallel to the low-power control circuit and the high-power output circuit; and

iv) connecting at least one resistive load having a resistance at least 10 times greater than the resistance R electrically between the first high-rate cell and the second high-rate cell.

27. A method of claim 26, wherein the at least one resistive load has a resistive value to limit, in the event of an internal short in one of the high-rate cells, the rate at which the shorted high-rate cell drains the other high-rate cell.

28. A method of claim 26, wherein the at least one resistive load value being between 10 ohms and 100 ohms.

29. A method of claim 26, wherein the first high-rate cell and the second high-rate cell has an electrode surface area up to 90 cm² each.

30. A method of claim 29, wherein the electrode surface area being between 65 cm² and 90 cm².

31. A method of claim 26, wherein the first high-rate cell and the second high-rate cell are maintained within a single case.

32. A method of claim 26, further comprising the step of connecting a switching circuit electrically between the first high-rate cell and the second high-rate cell for selectively coupling the first high-rate cell to the second high-rate cell upon activation of the high-power output circuit.

33. An implantable medical device comprising:

a hermetic enclosure;

a low-power control circuit located in the enclosure;

a high-power output circuit located in the enclosure for delivering an electrical pulse therapy; and

a power source and circuitry located in the enclosure for powering the low-power control circuit and the high-power output circuit, the power source and circuitry, said power source and circuitry further comprising;

a first high-rate cell;

a second high-rate cell;

wherein the first high-rate cell and second high-rate cell are electrically connected in parallel to the low-power control circuit and the high-power output circuit, the first high-rate cell and the second high-rate cell includes an anode, and further wherein the first high-rate cell and the second high-rate cell share a common cathode; and

at least one resistor electrically connected between the first high-rate cell and the second high-rate cell, the at least one resistive load having a resistive value to limit, in the event the first high-rate cell being internally shorted, the rate at which such internally shorted first high-rate cell drains the second high-rate cell, wherein the at least one resistive load value being between 10 ohms and 100 ohms,

wherein the first high-rate cell and the second high-rate cell include an electrode surface being between 65 cm² and 90 cm².